Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2002
by Triangle Pharmaceuticals.
Recruitment status was Active, not recruiting
Study NCT00044135 Information provided by Triangle Pharmaceuticals
First Received on August 20, 2002. Last Updated on June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
DNA Virus Infections
Hepatitis, Viral, Human
RNA Virus Infections
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers